Dr. Fabien Zoulim, MD, PhD is a Professor of Medicine at Lyon I University and Medical Director of the Hepatology Department at the Hospices Civils de Lyon.
His research interests focus on the understanding of viral persistence to discover and develop novel treatments to cure chronic HBV and HDV infections.
He is Director of the INSERM Unit 1350 PaThLiv “Pathobiology and Therapy of Liver Diseases” and founded the Lyon Hepatology Institute “IHU EVEREST” in 2023 (Center of Excellence label from the French Government). He is also the co-founder of the International Coalition to Eliminate HBV (ICE-HBV) and coordinates the ANRS “HBV cure” program in France since 2013.
Dr Zoulim has served as a governing board member and educational councilor of the European Association for the Study of the Liver (EASL) and as an associate editor of Journal of Hepatology and GUT.
He received several international awards including the Baruch Blumberg Award (2026), the Gertrude Elion Award from the International Society for Antiviral research (2023) and the Distinguished Award in HBV Research from the International HBV meeting (2022).